StageBio Acquires Alizée Pathology to Enhance High-Quality Histopathology and Medical Device Services

VCBeat (WeChat ID:vcbeat) According to foreign media, local time2019Year11Month7Day, Contract Research Organization, Preclinical Histology, Pathology, and Sample Archiving Service ProviderStageBioAnnounces Acquisition of One of North America’s Leading Preclinical Medical Device LaboratoriesAlizéePathology. Financial details of this acquisition have not been disclosed.

StageBio is a leading provider of GLP-compliant studies and preclinical histology, pathology, and sample archiving services for the biopharmaceutical, medical device, and contract research industries. The company offers comprehensive histopathology services to its clients, including tissue analysis, efficacy assessments for new compounds and devices, toxicological evaluations of FDA-approved products, detailed pathology reports for GLP studies, medical device pathology, and immunohistochemistry.

Alizée Pathology, established in 2010, is one of North America’s leading preclinical medical device laboratories. Co-founded by Dr. Serge Rousselle and Joan Wicks, the company provides GLP-compliant services to support the development of novel devices and therapeutic agents. Alizée offers preclinical medical services spanning bone repair, interventional medicine, oncology, inflammatory diseases, immunotherapy, regenerative medicine, surgical tools, and drug and tissue phenotypic analysis.

Mr. Thomas Galati, CEO of StageBio, stated, “Dr. Serge Rousselle, Dr. Joan Wicks, and the Alizée team bring unique histopathology services to StageBio. These capabilities enable us to provide the industry with a broader range of highly specialized histopathology and imaging services. Having previously successfully integrated HSRL, VPS, and TPS, we are delighted to add Alizée’s technical expertise to our growing portfolio.”

Dr. Serge Rousselle, Co-Founder of Alizée Pathology, commented, “StageBio and Alizée have cultivated a close partnership over the years, and the current merger is a natural evolution of that relationship. StageBio’s extensive client base and services, combined with Alizée’s expertise, make for a successful combination. Post-merger, we will expand laboratory space in Thurmont and Cumberland and bring in experienced talent specializing in medical devices and biologics. This will complement the StageBio teams in Virginia, Massachusetts, Ohio, and Maryland. Furthermore, the company will hire 28 board-certified (ACVP) veterinary pathologists, bringing the total number of employees to over 150.”

(Compiled by: Xiong Hui)